New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
10:00 EDTFCX, SNBC, MON, AYI, SPLK, OPEN, INTC, EEP, WSH, NFX, LLYOn The Fly: Analyst Upgrade Summary
Acuity Brands (AYI) upgraded to Buy from Hold at Canaccord... Eli Lilly (LLY) upgraded to Outperform from Market Perform at Cowen... Intel (INTC) upgraded to Overweight from Neutral at Piper Jaffray... Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan... Newfield Exploration (NFX) upgraded to Buy from Neutral at UBS... OpenTable (OPEN) upgraded to Buy from Neutral at Citigroup... Sun Bancorp (SNBC) upgraded to Neutral from Underperform at Sterne Agee... Willis Group (WSH) upgraded to Buy from Neutral at Nomura... Splunk (SPLK) upgraded to Outperform from Underperform at CLSA... Freeport McMoRan (FCX) upgraded to Outperform from Neutral at Macquarie... Enbridge Energy (EEP) upgraded at Credit Suisse.
News For AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
June 22, 2015
09:40 EDTINTCActive equity options trading on open
Subscribe for More Information
08:39 EDTLLYBernstein pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
08:35 EDTINTCKopin divests interest in Recon Instruments
Kopin (KOPN) said it had divested its equity interest in Recon Instruments as part of Intel Corporationís (INTC) acquisition of Recon. Kopin anticipates that it will receive approximately $6M in cash proceeds for its equity interest, subject to certain closing conditions including a working capital adjustment.
June 21, 2015
16:32 EDTINTCAMD considers spinoff or break-up, Reuters says
AMD (AMD) has hired a consulting firm to help it review a potential split or spinoff, Reuters reported late Friday, citing three people familiar with the matter. Reuters notes that AMD may be seeking to better compete with Intel (INTC), and sources said one option being considered is to separate AMD's server business from its graphics and licensing arm. Though the company had previously decided against such an option, sources noted that CEO Lisa Su believes the move is worth reconsidering. Reference Link
June 19, 2015
10:34 EDTLLYEli Lilly to host conference call
Subscribe for More Information
08:39 EDTMONMonsanto volatility elevated into Q3 and outlook
Monsanto June weekly option implied volatility is at 29, July and October is at 22; compared to its 52-range of 14 to 27, suggesting large near term price movement into its expected release of Q3 results on June 24.
08:04 EDTLLYEli Lilly publishes results of Phase III REACH trial evaluating Cyramza
Subscribe for More Information
07:23 EDTLLYTeva data quite strong, says Bernstein
After Teva (TEVA) announced data for its TEV-48125 drug in episodic migraine, Bernstein notes that the drug met its primary and secondary endpoints. The firm says that the reduction in migraine days of Teva's drug appears to be higher than what Amgen (AMGN) and Lilly (LLY) have shown. The firm continues to see the migraine treatments from Teva and Alder as better than those from Lilly and Amgen.
06:26 EDTINTCIntel CEO confirms recent reports of layoffs, The Oregonian reports
Subscribe for More Information
June 18, 2015
10:46 EDTFCXStocks with call strike movement; FCX AAL
Subscribe for More Information
08:59 EDTNFXNewfield Exploration upgraded on Anadarko Basin potential at Stifel
As noted earlier, Stifel upgraded Newfield to Buy from Hold. As reasons for the upgrade, the firm cited the company's success in the Anadarko Basin and its belief that the STACK and SCOOP portions of the region could unlock significant value for the company.Target $48.
06:33 EDTNFXNewfield Exploration upgraded to Buy from Hold at Stifel
Subscribe for More Information
05:56 EDTINTCIntel to debut Skylake at Gamescon in early August, DigiTimes reports
Subscribe for More Information
June 17, 2015
12:11 EDTINTCIntel acquires Recon, terms not disclosed
Subscribe for More Information
12:02 EDTLLYEli Lilly reports LY2951742 meets primary endpoint in Phase 2b migraine study
Eli Lilly announced that its investigational medicine for prevention of migraine -- LY2951742, a CGRP neutralizing antibody -- met the primary endpoint in a Phase 2b study in episodic migraine. The randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of four different doses of LY2951742 given in a once-monthly, subcutaneous injection in more than 400 patients with episodic migraine. The primary objective was to assess whether at least one dose of LY2951742 was superior to placebo in the prevention of migraine headache. LY2951742 demonstrated a statistically significant reduction in migraine headache days and a safety and tolerability profile confirming the previous results seen in a Phase 2a study. In addition to the migraine program, Lilly has initiated two Phase 3 trials with LY2951742 in patients suffering from cluster headache. Based on the unmet medical need and significance of this disorder for patients, Lilly has been granted fast track designation from the U.S. FDA for cluster headache.
10:00 EDTLLYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
08:10 EDTLLYEli Lilly and Dana-Farber Cancer Institute enter research collaboration
Subscribe for More Information
08:02 EDTLLYEli Lilly partnering with Sarah Cannon Research Institute for oncology therapy
Eli Lilly and Sarah Cannon Research Institute announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.
07:25 EDTLLYPiper calls Bristol 'modestly overvalued,' starts shares with sell
Subscribe for More Information
05:31 EDTLLYEli Lilly initiated with an Overweight at Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use